Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

YAP mediates crosstalk between the Hippo and PI(3)K–TOR pathways by suppressing PTEN via miR-29.

Tumaneng K, Schlegelmilch K, Russell RC, Yimlamai D, Basnet H, Mahadevan N, Fitamant J, Bardeesy N, Camargo FD, Guan KL.

Nat Cell Biol. 2012 Dec;14(12):1322-9.

2.

Hippo-YAP and mTOR pathways collaborate to regulate organ size.

Csibi A, Blenis J.

Nat Cell Biol. 2012 Dec;14(12):1244-5. doi: 10.1038/ncb2634.

PMID:
23196842
3.

Hippo signaling regulates pancreas development through inactivation of Yap.

George NM, Day CE, Boerner BP, Johnson RL, Sarvetnick NE.

Mol Cell Biol. 2012 Dec;32(24):5116-28. doi: 10.1128/MCB.01034-12.

4.

Targeting YAP and Hippo signaling pathway in liver cancer.

Liu AM, Xu MZ, Chen J, Poon RT, Luk JM.

Expert Opin Ther Targets. 2010 Aug;14(8):855-68. doi: 10.1517/14728222.2010.499361. Review.

PMID:
20545481
5.

Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung.

Lange AW, Sridharan A, Xu Y, Stripp BR, Perl AK, Whitsett JA.

J Mol Cell Biol. 2015 Feb;7(1):35-47. doi: 10.1093/jmcb/mju046.

6.

Integration of Hippo signalling and the unfolded protein response to restrain liver overgrowth and tumorigenesis.

Wu H, Wei L, Fan F, Ji S, Zhang S, Geng J, Hong L, Fan X, Chen Q, Tian J, Jiang M, Sun X, Jin C, Yin ZY, Liu Q, Zhang J, Qin F, Lin KH, Yu JS, Deng X, Wang HR, Zhao B, Johnson RL, Chen L, Zhou D.

Nat Commun. 2015 Feb 19;6:6239. doi: 10.1038/ncomms7239.

PMID:
25695629
7.

A functional interaction between Hippo-YAP signalling and FoxO1 mediates the oxidative stress response.

Shao D, Zhai P, Del Re DP, Sciarretta S, Yabuta N, Nojima H, Lim DS, Pan D, Sadoshima J.

Nat Commun. 2014;5:3315. doi: 10.1038/ncomms4315.

8.

Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex.

Liang N, Zhang C, Dill P, Panasyuk G, Pion D, Koka V, Gallazzini M, Olson EN, Lam H, Henske EP, Dong Z, Apte U, Pallet N, Johnson RL, Terzi F, Kwiatkowski DJ, Scoazec JY, Martignoni G, Pende M.

J Exp Med. 2014 Oct 20;211(11):2249-63. doi: 10.1084/jem.20140341.

9.

Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.

Chen M, Wang M, Xu S, Guo X, Jiang J.

Oncotarget. 2015 Dec 29;6(42):44466-79. doi: 10.18632/oncotarget.6298.

10.

Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1.

Fan R, Kim NG, Gumbiner BM.

Proc Natl Acad Sci U S A. 2013 Feb 12;110(7):2569-74. doi: 10.1073/pnas.1216462110.

11.

KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammals.

Moleirinho S, Chang N, Sims AH, Tilston-Lünel AM, Angus L, Steele A, Boswell V, Barnett SC, Ormandy C, Faratian D, Gunn-Moore FJ, Reynolds PA.

Oncogene. 2013 Apr 4;32(14):1821-30. doi: 10.1038/onc.2012.196.

PMID:
22614006
12.

Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility.

Wang Z, Wu Y, Wang H, Zhang Y, Mei L, Fang X, Zhang X, Zhang F, Chen H, Liu Y, Jiang Y, Sun S, Zheng Y, Li N, Huang L.

Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):E89-98. doi: 10.1073/pnas.1319190110. Erratum in: Proc Natl Acad Sci U S A. 2016 Nov 14;:. Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):E7641-E7642.

13.

Phosphorylation of the Hippo Pathway Component AMOTL2 by the mTORC2 Kinase Promotes YAP Signaling, Resulting in Enhanced Glioblastoma Growth and Invasiveness.

Artinian N, Cloninger C, Holmes B, Benavides-Serrato A, Bashir T, Gera J.

J Biol Chem. 2015 Aug 7;290(32):19387-401. doi: 10.1074/jbc.M115.656587.

14.

Bile acids activate YAP to promote liver carcinogenesis.

Anakk S, Bhosale M, Schmidt VA, Johnson RL, Finegold MJ, Moore DD.

Cell Rep. 2013 Nov 27;5(4):1060-9. doi: 10.1016/j.celrep.2013.10.030.

15.

A miR-130a-YAP positive feedback loop promotes organ size and tumorigenesis.

Shen S, Guo X, Yan H, Lu Y, Ji X, Li L, Liang T, Zhou D, Feng XH, Zhao JC, Yu J, Gong XG, Zhang L, Zhao B.

Cell Res. 2015 Sep;25(9):997-1012. doi: 10.1038/cr.2015.98.

16.

Upregulation of miR-130b enhances stem cell-like phenotype in glioblastoma by inactivating the Hippo signaling pathway.

Zhu G, Wang Y, Mijiti M, Wang Z, Wu PF, Jiafu D.

Biochem Biophys Res Commun. 2015 Sep 18;465(2):194-9. doi: 10.1016/j.bbrc.2015.07.149.

PMID:
26241672
17.

A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis.

Moroishi T, Park HW, Qin B, Chen Q, Meng Z, Plouffe SW, Taniguchi K, Yu FX, Karin M, Pan D, Guan KL.

Genes Dev. 2015 Jun 15;29(12):1271-84. doi: 10.1101/gad.262816.115.

18.

Regulation of YAP by mechanical strain through Jnk and Hippo signaling.

Codelia VA, Sun G, Irvine KD.

Curr Biol. 2014 Sep 8;24(17):2012-7. doi: 10.1016/j.cub.2014.07.034.

19.

Tumor suppressor LATS1 is a negative regulator of oncogene YAP.

Hao Y, Chun A, Cheung K, Rashidi B, Yang X.

J Biol Chem. 2008 Feb 29;283(9):5496-509.

20.

Dynamic alterations in Hippo signaling pathway and YAP activation during liver regeneration.

Grijalva JL, Huizenga M, Mueller K, Rodriguez S, Brazzo J, Camargo F, Sadri-Vakili G, Vakili K.

Am J Physiol Gastrointest Liver Physiol. 2014 Jul 15;307(2):G196-204. doi: 10.1152/ajpgi.00077.2014.

Items per page

Supplemental Content

Support Center